Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShearwater Regulatory News (SWG)

Share Price Information for Shearwater (SWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.00
Bid: 42.00
Ask: 44.00
Change: -1.50 (-3.37%)
Spread: 2.00 (4.762%)
Open: 44.00
High: 44.00
Low: 42.50
Prev. Close: 44.50
SWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Schedule 1 - Shearwater Group Plc

24 Apr 2017 08:00

RNS Number : 0499D
AIM
24 April 2017
 

 

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

Shearwater Group plc

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

22 Great James Street

London WC1N 3ES

 

COUNTRY OF INCORPORATION:

England and Wales

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

www.theshearwatergroup.co.uk

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

 

In 2016 and 2017, the Company appointed a number of new Directors and have in 2017, assembled an operating team with substantial experience within the high technology, cyber, information security, digital and communications sectors, with a track record of delivering shareholder value through accelerated buy and build processes. The Company intends to leverage this experience to create a UK based group providing digital resilience solutions. In support of this strategy, the Company completed two placings in 2016, raising in excess of £7 million of gross proceeds to help fund initial acquisitions, due diligence exercises and the general operating expenses of the Company.

 

The Company has conditionally agreed to acquire:

 

· The entire share capital of SecureEnvoy Limited, one of the UK's leading providers of multifactor authentication enterprise software solutions (the "Transaction"). SecureEnvoy is headquartered in the UK, with end users across the US, Europe and Australia.

 

The consideration for the Transaction is (i) £10 million in cash and (ii) £10 million of shares in the Company at a price of 5 pence per share.

 

The cash consideration of the Transaction will be financed through existing cash resources in addition to a fundraising consisting of a conditional placing and an open offer (the "Fundraising"). The Transaction and the Fundraising are inter-conditional.

 

The Transaction constitutes a reverse takeover under AIM Rule 14 and accordingly, the Company will seek readmission ("Admission") of its shares to trading on AIM of the London Stock Exchange.

 

The Transaction and associated fundraising will be subject to the passing of relevant resolutions at the Company's general meeting to be held on 8 May 2017.

 

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

Up to 960,738,394 ordinary shares of 1 penny each ("Ordinary Shares") (assuming full take up under the Open Offer)

No shares held in treasury.

No restrictions as to transfer of the securities.

 

CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

Capital raised on admission £8 million

 

Implied market capitalisation £38.4 million (assuming full take up under the Open Offer at the Issue Price)

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

Before Admission 40.86 per cent.

Post Admission 49.58 per cent.

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES (INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED:

None

 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

David Jeffreys Williams (Chairman)

Michael Joseph ("Mo") Stevens (Chief Executive Officer)

Robin Simon Southwell (Non-Executive Director)

Stephen Robert Ball (Non-Executive Director)

Giles Kirkley Willits (Non-Executive Director)

Christopher John Eadie (Executive Director)

 

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

Before Admission:

David Jeffreys Williams

18.89

Schroder Investment Management

14.01

Killik & Co

7.24

HSBC Bank plc

6.35

Tiger Brave Investments Limited

5.73

Blankstone Sington

4.38

Spreadex Limited

3.83

 

Following Admission:

David Jeffreys Williams

12.14

Schroder Investment Management

11.23

Andrew Kemshall

9.32

Steven Watts

9.32

Hargreave Hale

6.38

Killik & Co

5.08

Columbia Threadneedle

4.79

HSBC Bank plc

3.64

Tiger Brave Investments

3.28

 

 

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

None

 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

(i) 31 March

 

(ii) Target's information to 31 December 2016. Shearwater financial information up to interim results to 30 September 2016 is incorporated by reference.

 

(iii) Annual report for the year ended 31 March 2017 published by 30 September 2017. Half year report for the six months ended 30 September 2017 published by 31 December 2017. Annual report for the year ended 31 March 2018 published by 30 September 2018.

 

EXPECTED ADMISSION DATE:

9 May 2017

 

NAME AND ADDRESS OF NOMINATED ADVISER:

WH Ireland Limited

24 Martin Lane

London EC4R 0DR

 

NAME AND ADDRESS OF BROKER:

WH Ireland Limited

24 Martin Lane

London EC4R 0DR

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

Not applicable

 

DATE OF NOTIFICATION:

24 April 2017

 

NEW/ UPDATE:

New

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PAABLGDSSSDBGRB
Date   Source Headline
9th Dec 202112:49 pmRNSHolding(s) in Company
8th Dec 20217:00 amRNSDirector/PDMR Shareholding
25th Nov 20217:00 amRNSResults for the six months ended 30 September 2021
16th Nov 20217:00 amRNSNotice of Results and Presentation to Investors
2nd Nov 20217:00 amRNSTrading Update
22nd Sep 20212:55 pmRNSResult of AGM
15th Sep 20217:00 amRNSContract Renewal
7th Sep 20217:00 amRNSContract Renewal
31st Aug 20215:05 pmRNSNotice of AGM and Posting of Annual Report
9th Aug 20215:43 pmRNSDirector/PDMR Shareholding
28th Jul 20217:00 amRNSFinal Results
20th Jul 20217:00 amRNSNotice of Results and Presentation to Investors
13th Jul 202111:39 amRNSHolding(s) in Company
6th May 20217:00 amRNSFramework Agreement Renewal
30th Apr 20213:21 pmRNSHolding(s) in Company
22nd Apr 20217:00 amRNSPost Close Trading Update
12th Mar 202110:42 amRNSHolding(s) in Company
26th Feb 20217:00 amRNSExercise of options
22nd Feb 20213:11 pmRNSHolding(s) in Company
15th Feb 202110:02 amRNSHolding(s) in Company
26th Jan 20217:00 amRNSGrant of Options under SAYE Scheme
11th Jan 20212:54 pmRNSHolding(s) in Company
6th Jan 20217:00 amRNSContract Win
29th Dec 20207:00 amRNSTrading update and New contracts secured
16th Dec 20207:00 amRNSHolding(s) in Company
8th Dec 20209:47 amRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNSResults for the six months ended 30 September 2020
12th Nov 20207:00 amRNSNotice of Results and Presentation to Investors
22nd Oct 20207:00 amRNSH1 Trading update
25th Sep 20207:00 amRNSResult of AGM
14th Sep 20201:29 pmRNSRelease of Holdback Consideration Shares
1st Sep 20207:00 amRNSPosting of Annual Report and Notice of AGM
20th Aug 20207:00 amRNSTrading Update
29th Jul 20207:00 amRNSFinal Results
30th Jun 20207:00 amRNSNotice of Results
24th Apr 20204:41 pmRNSSecond Price Monitoring Extn
24th Apr 20204:35 pmRNSPrice Monitoring Extension
24th Apr 20201:58 pmRNSResults of Placing and Total Voting Rights
24th Apr 20207:00 amRNSProposed placing
2nd Apr 20207:00 amRNSPre-close statement
27th Mar 20207:00 amRNSContract win
25th Mar 20207:00 amRNSStatement re COVID-19 and contract wins
24th Mar 20205:44 pmRNSHolding(s) in Company
26th Feb 20207:00 amRNSIssue of Equity
27th Nov 20197:00 amRNSInterim Results
19th Nov 201911:30 amRNSNotice of Results
30th Oct 20197:00 amRNSBrookcourt Solutions secures EUR 0.5 M contract
28th Oct 20198:53 amRNSDirector/PDMR Shareholding
24th Oct 20197:01 amRNSHalf year trading update
22nd Oct 20197:00 amRNSGroup wins 5 awards at Computing Security Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.